Literature DB >> 9528827

Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells.

A S Ojugo1, P M McSheehy, M Stubbs, G Alder, C L Bashford, R J Maxwell, M O Leach, I R Judson, J R Griffiths.   

Abstract

To investigate the possible dependence of 5-fluorouracil (5FU) uptake in tumours on the intra- (pHi) and extracellular (pHe) pH, a pH gradient (deltapH) was imposed across the plasma membrane of ascites tumour cells in vitro, similar to that known to occur in some solid tumours in vivo, by incubation in media of PHe 5-8. A > or = 2:1 (intracellular/extracellular) accumulation of radiolabelled 5FU occurred after 5 min incubation of the cells with 0.5 mM 5FU at pHe of 5.0, 5.5 or 6.0. 5FU metabolism is slow under these conditions, and 5FU uptake was not affected by longer incubations up to 20 min, nor by the absence of a sodium gradient. pHi was estimated from the distribution of the weak acid, 5.5-dimethyl-2,4-oxazolidione ([14C]DMO) across the cell membrane. There was significant correlation between the intracellular/extracellular 5FU ratio and pHe (from pHe 6-8), deltapH and pHi (P < 0.02). Similar results were obtained with HT29 cells. Incubation with a drug that made plasma membranes permeable to H+ significantly decreased 5FU uptake in Lettre cells. The co-transport of 5FU may occur on a proton symport using the proton motive force of the deltapH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528827      PMCID: PMC2150086          DOI: 10.1038/bjc.1998.144

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

2.  Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

Authors:  J L Cohen; L E Irwin; G J Marshall; H Darvey; J R Bateman
Journal:  Cancer Chemother Rep       Date:  1974 Sep-Oct

Review 3.  Fluorinated pyrimidines and their nucleosides.

Authors:  C Heidelberger; P V Danenberg; R G Moran
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1983

4.  Active transport of 5-fluorouracil and its energy coupling in Ehrlich ascites tumor cells.

Authors:  S Yamamoto; T Kawasaki
Journal:  J Biochem       Date:  1981-09       Impact factor: 3.387

5.  A novel method for measuring intracellular pH and potassium concentration.

Authors:  C L Bashford; G Alder; K J Micklem; C A Pasternak
Journal:  Biosci Rep       Date:  1983-07       Impact factor: 3.840

6.  Plasma membrane potential of Lettré cells does not depend on cation gradients but on pumps.

Authors:  C L Bashford; C A Pasternak
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

7.  Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.

Authors:  W Wolf; C A Presant; K L Servis; A el-Tahtawy; M J Albright; P B Barker; R Ring; D Atkinson; R Ong; M King
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.

Authors:  J L Au; J S Walker; Y Rustum
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

Review 9.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

10.  Enzymes of uracil catabolism in normal and neoplastic human tissues.

Authors:  F N Naguib; M H el Kouni; S Cha
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

View more
  10 in total

Review 1.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

2.  Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure.

Authors:  Hanneke W M van Laarhoven; Giulio Gambarota; Jasper Lok; Martin Lammens; Yvonne L M Kamm; Theo Wagener; Cornelis J A Punt; Albert J van der Kogel; Arend Heerschap
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

3.  Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery.

Authors:  Seong Deok Kong; Alice Luong; Gerald Manorek; Stephen B Howell; Jerry Yang
Journal:  Bioconjug Chem       Date:  2007-01-30       Impact factor: 4.774

4.  A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU.

Authors:  Y Tsukamoto; Y Kato; M Ura; I Horii; H Ishitsuka; H Kusuhara; Y Sugiyama
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

5.  Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Authors:  Cary A Presant; Joth Jacobson; Walter Wolf; Victor Waluch; Ilene C Weitz; John S Macdonald
Journal:  Invest New Drugs       Date:  2002-11       Impact factor: 3.850

6.  Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.

Authors:  Terence P F Gade; Ian M Buchanan; Matthew W Motley; Yousef Mazaheri; William M Spees; Jason A Koutcher
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

7.  Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Authors:  Hanan Abumanhal-Masarweh; Lilach Koren; Assaf Zinger; Zvi Yaari; Nitzan Krinsky; Galoz Kaneti; Nitsan Dahan; Yael Lupu-Haber; Edith Suss-Toby; Esther Weiss-Messer; Michal Schlesinger-Laufer; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-01-05       Impact factor: 9.776

8.  Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?

Authors:  Dominick J O McIntyre; Franklyn A Howe; Christophe Ladroue; Fiona Lofts; Marion Stubbs; John R Griffiths
Journal:  Cancer Chemother Pharmacol       Date:  2010-09-07       Impact factor: 3.333

Review 9.  Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations.

Authors:  K J Williams; R L Cowen; I J Stratford
Journal:  Breast Cancer Res       Date:  2001-08-07       Impact factor: 6.466

10.  Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization.

Authors:  Harihar Basnet; Lin Tian; Karuna Ganesh; Yun-Han Huang; Danilo G Macalinao; Edi Brogi; Lydia Ws Finley; Joan Massagué
Journal:  Elife       Date:  2019-03-26       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.